Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Suppressor leukocytes in anergic patients with solid tumors
A. D. Bankhurst
, G. R. Kauffman
,
J. S. Goodwin
, J. H. Saiki
, J. H. Saiers
, R. C. Williams
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Suppressor leukocytes in anergic patients with solid tumors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Suppressor Cells
100%
Leukocytes
100%
Solid Tumors
100%
Anergic
100%
Cancer Patients
50%
Increased Activity
33%
In Vitro Assay
16%
Prostaglandins
16%
Lymphocyte Proliferation
16%
Phytohemagglutinin
16%
Concanavalin A (Con A)
16%
Cell-based Assay
16%
Enhanced Activity
16%
T-cell Immunodeficiency
16%
Suppression Mechanism
16%
Immunology and Microbiology
Suppressor Cell
100%
Leukocyte
100%
In Vitro
33%
T Cell
16%
Prostaglandin
16%
Normal Human
16%
Lymphocyte Proliferation
16%
Immunodeficiency
16%
Phytohaemagglutinin
16%
Cell Assay
16%
Concanavalin A
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Solid Malignant Neoplasm
100%
Normal Human
33%
Prostaglandin
33%
Concanavalin A
33%
Phytohaemagglutinin
33%
Immune Deficiency
33%